Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality

Mechanisms of Ageing and Development

Volumn 110, Issue 3, 1999, Pages 175-193

  Ishii, Yuriko ^a   Tsuyama, Naohiro ^a   Maeda, Shizuko ^a   Tahara, Hidetoshi ^a   Ide, Toshinori ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell fusion; Complementation group; Telomerase; Telomerase negative immortal cells

Indexed keywords

TELOMERASE;

ARTICLE; CELL DIVISION; CELL FUSION; CELL HYBRIDIZATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REPRESSION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HYBRID CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASE SEQUENCE; CELL AGING; CELL DIVISION; CELL FUSION; CELL LINE; DNA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC COMPLEMENTATION TEST; HUMANS; HYBRID CELLS; PHENOTYPE; TANDEM REPEAT SEQUENCES; TELOMERASE;

EID: 0032851592     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(99)00054-8     Document Type: Article

References (36)

1. Aden, D.P., Fogel, A., Plotkin, S., Damjanov, I., Knowles, B.B., 1979. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282, 615-616.
2. Autexier, C., Greider, C.W., 1996. Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem. Sci. 21, 387-391.
3. Blackburn, E.H., 1991. Structure and function of telomeres. Nature 350, 569-573.
4. Blochlinger, K., Diggelmann, H., 1984. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol. Cell. Biol. 4, 2929-2931.
5. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S., Reddel, R.R., 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248.
6. Bryan, T.M., Marusic, L., Bacchetti, S., Namba, M., Reddel, R.R., 1997. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet. 6, 921-926.
7. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., Bacchetti, S., 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
8. de Lange, T., 1998. Ending up with the right partner. Nature 392, 753-754.
9. Enoch, T., Norbury, C., 1995. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20, 426-430.
10. Gey, G.O., Coffman, W.D., Kuvicek, M.T., 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12, 264-265.
11. Girardi, A.J., Weinstein, D., Moorhead, P.S., 1966. SV40 transformation of human diploid cells. A parallel study of viral and karyologic parameters. Ann. Med. Exp. Biol. Fenn. 44, 242-254.
12. Harley, C.B., Futcher, A.B., Greider, C.W., 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
13. Hoshi, H., Kan, M., Yamane, I., Ohno, T., Namba, M., 1983. Differential growth requirements of serum factors (bovine serum albumin and low density lipoprotein) for normal and transformed human cells in a serum-free culture. Cell Struct. Funct. 8, 67-75.
14. Izumi, M., Miyazawa, H., Kamakura, T., Yamaguchi, I., Endo, T., Hanaoka, F., 1991. Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp. Cell Res. 197, 229-233.
15. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., Shay, J.W., 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
16. Konig, P., Rhodes, D., 1997. Recognition of telomeric DNA. Trends Biochem. Sci. 22, 43-47.
17. Matsuo, M., Kaji, K., Utakoji, T., Hosoda, K., 1982. Ploidy of human embryonic fibroblasts during in vitro aging. J. Gerontol. 37, 33-37.
18. Murnane, J.P., Sabatier, L., Marder, B.A., Morgan, W.F., 1994. Telomere dynamics in an immortal human cell line. EMBO J. 13, 4953-4962.
19. Namba, M., Nishitani, K., Hyodoh, F., Fukushima, F., Kimoto, T., 1985. Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays. Int. J. Cancer 35, 275-280.
20. Ning, Y., Weber, J.L., Killary, A.M., Ledbetter, D.H., Smith, J.R., Pereira-Smith, O.M., 1991. Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc. Natl. Acad. Sci. U.S.A. 88, 5635-5639.
21. Ogata, T., Oshimura, M., Namba, M., Fujii, M., Oishi, M., Ayusawa, D., 1995. Genetic complementation of the immortal phenotype in group D cell lines by introduction of chromosome 7. Jpn. J. Cancer Res. 86, 35-40.
22. Ohmura, H., Tahara, H., Suzuki, M., Ide, T., Shimizu, M., Yoshida, M.A., Tahara, E., Shay, J.W., Barrett, J.C., Oshimura, M., 1995. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn. J. Cancer Res. 86, 899-904.
23. Pereira-Smith, O.M., Smith, J.R., 1983. Evidence for the recessive nature of cellular immortality. Science 221, 964-966.
24. Pereira-Smith, O.M., Smith, J.R., 1988. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc. Natl. Acad. Sci. U.S.A. 85, 6042-6046.
25. Rasheed, S., Nelson-Rees, W.A., Toth, E.M., Arnstein, P., Gardner, M.B., 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33, 1027-1033.
26. Sandhu, A.K., Hubbard, K., Kaur, G.P., Jha, K.K., Ozer, H.L., Athwal, R.S., 1994. Senescence of immortal human fibroblasts by the introduction of normal human chromosome 6. Proc. Natl. Acad. Sci. U.S.A. 91, 5498-5502.
27. Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., zur Hausen, H., 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
28. Sharma, H.W., Sokoloski, J.A., Perez, J.R., Maltese, J.Y., Sartorelli, A.C., Stein, C.A., Nichols, G., Khaled, Z., Telang, N.T., Narayanan, R., 1995. Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. U.S.A. 92, 12343-12346.
29. Sherman, J.M., Pillus, L., 1997. An uncertain silence. Trends Genet. 13, 308-313 [see comments].
30. Shore, D., 1997. Telomerase and telomere-binding proteins: controlling the endgame. Trends Biochem. Sci. 22, 233-235.
31. Stoppler, H., Hartmann, D.P., Sherman, L., Schlegel, R., 1997. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J. Biol. Chem. 272, 13332-13337.
32. Strahl, C., Blackburn, E.H., 1996. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol. 16, 53-65.
33. Sugihara, S., Mihara, K., Marunouchi, T., Inoue, H., Namba, M., 1996. Telomere elongation observed in immortalized human fibroblasts by treatment with 60Co gamma rays or 4-nitroquinoline 1-oxide. Hum. Genet. 97, 1-6.
34. Tokutake, Y., Matsumoto, T., Watanabe, T., Maeda, S., Tahara, H., Sakamoto, S., Niida, H., Sugimoto, M., Ide, T., Furuichi, Y., 1998. Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247, 765-772.
35. Tsuyama, N., Miura, M., Kitahira, M., Ishibashi, S., Ide, T., 1991. SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblasts. Cell Struct. Funct. 16, 55-62.
36. Wadhwa, R., Kaul, S.C., Ikawa, Y., Sugimoto, Y., 1993. Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J. Biol. Chem. 268, 6615-6621.